Eyecare professionals examine the emerging role of miotic agents as promising treatment options for the management of patients with presbyopia.
EP. 1: Overview of Presbyopia
Francis S. Mah, MD, and Andrew S. Morgenstern, OD, FAAO, FNAP, review the impact of presbyopia on quality of life as well as current treatment options and unmet needs for disease management.
EP. 2: Impact of Presbyopia on Mechanism of Ocular Accommodation
Drs Andrew S. Morgenstern and Francis S. Mah provide insight on the functionality of ocular accommodation as an autofocus lens and how this is affected in patients with presbyopia.
EP. 3: Miotic Treatment Options for Presbyopia
Francis S. Mah, MD, reviews miotic agents that are available or under investigation for the treatment of presbyopia.
EP. 4: Miotic Selectivity in the Management of Presbyopia
Andrew S. Morgenstern discusses the selectivity of miotic agents in isolating the pupil while limiting adverse events for the management of presbyopia.
EP. 5: ICYMI: Targeting Pupil Size for Presbyopia Management
Andrew S. Morgenstern, OD, FAAO, FNAP, highlights the importance of reducing pupil size to a certain level to optimize near vision for patients with presbyopia.
EP. 6: ICYMI: Using Miotic Agents for the Management of Presbyopia
Expert eye care specialists discuss the role of miotic agents in targeting presbyopia in patients.
EP. 7: Role of Aceclidine in Presbyopia Treatment
Expert eye care specialists comment on the use of aceclidine as a selective miotic for the treatment of presbyopia.
2 Clarke Drive Cranbury, NJ 08512